⌘K
Loading ticker…
As of 2026-08-24, ImmunityBio, Inc. Common Stock (IBRX) has a 3-month relative strength percentile of 58 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 78. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.8%, relative volume 0.65×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
IBRX is held by 24 ETFs as of May 2026. Top owner: VTWO at 0.07% weight, $11M notional. Top 3 carry $30M.
Held by 54 ETFs · $455M across latest filings · largest weight 4.80% (BBP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.07% | $11M | −0.03 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $11M | −0.02 pp |
| VHTVanguard Health Care ETF | 0.04% | $8M | — |
| VFMO | 0.12% | $2M | +0.03 pp |
| ONEQ | 0.02% | $2M | −0.01 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.10% |
| $2M |
| −0.05 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $1M | — |
| FSCC | 0.25% | $685K | −0.09 pp |
| IBBQ | 0.62% | $414K | −0.11 pp |
| VTWV | 0.02% | $310K | — |
Showing 10 of 24 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IBRX Jan avg: 48.08% median: 4.86% win: 50% σ: 115.75% n: 4 2022-04-12 → 2026-07-31 | IBRX Feb avg: 14.21% median: 18.07% win: 50% σ: 42.22% n: 4 2022-04-12 → 2026-07-31 | IBRX Mar avg: -10.49% median: -15.04% win: 25% σ: 17.57% n: 4 2022-04-12 → 2026-07-31 | IBRX Apr avg: 10.45% median: -7.43% win: 40% σ: 37.95% n: 5 2022-04-12 → 2026-07-31 | IBRX May avg: -1.19% median: 3.58% win: 60% σ: 10.79% n: 5 2022-04-12 → 2026-07-31 | IBRX Jun avg: 2.83% median: -0.75% win: 40% σ: 7.66% n: 5 2022-04-12 → 2026-07-31 | IBRX Jul avg: -11.95% median: -18.10% win: 20% σ: 10.72% n: 5 2022-04-12 → 2026-07-31 | IBRX Aug avg: -13.04% median: -14.09% win: 25% σ: 14.30% n: 4 2022-04-12 → 2026-07-31 (current) | IBRX Sep avg: 7.13% median: 5.05% win: 75% σ: 12.51% n: 4 2022-04-12 → 2026-07-31 | IBRX Oct avg: 33.52% median: 25.36% win: 75% σ: 39.12% n: 4 2022-04-12 → 2026-07-31 | IBRX Nov avg: 3.11% median: -0.74% win: 50% σ: 9.50% n: 4 2022-04-12 → 2026-07-31 | IBRX Dec avg: -9.22% median: -12.04% win: 25% σ: 35.26% n: 4 2022-04-12 → 2026-07-31 |